| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/24/2009 | US20090238816 Method for immunizing an avian species |
| 09/24/2009 | US20090238795 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors |
| 09/24/2009 | US20090238791 Il-15ralpha sushi domain as a selective and potent enhancer of il-15 action through il-15beta/gamma, and hyperagonist (il-15ralpha sushi - il-15) fusion proteins |
| 09/24/2009 | US20090238763 High penetration compositions and uses thereof |
| 09/24/2009 | US20090238762 Method for treating joint damage |
| 09/24/2009 | CA2719134A1 Treatment with opioid antagonists and mtor inhibitors |
| 09/24/2009 | CA2718634A1 Antibodies against interleukin-10-like cytokines and uses therefor |
| 09/24/2009 | CA2718551A1 Substituted sulfonamide derivatives |
| 09/24/2009 | CA2718526A1 Organic compounds |
| 09/24/2009 | CA2717934A1 Process for the preparation of 2-amino-2- [2-(4-c3-c21-alkyl-phenyl)ethyl] propane-1,3-diols |
| 09/24/2009 | CA2714708A1 Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase |
| 09/23/2009 | EP2103691A1 T helper cell epitopes |
| 09/23/2009 | EP2103629A1 Gamma -1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 09/23/2009 | EP2102195A1 Crystal modifications -3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl]-pyrrole-2, 5-d ione |
| 09/23/2009 | EP2102169A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 09/23/2009 | EP2102162A1 Phenylic derivatives and use thereof as drugs |
| 09/23/2009 | EP2101818A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 09/23/2009 | EP2101810A2 Chymosin for the prevention and treatment of gastrointestinal disorders |
| 09/23/2009 | EP2101754A1 Use of entacapone in cosmetic, dermatological and pharmaceutical compositions |
| 09/23/2009 | EP1478662B1 Method for producing hypoallergenic major birch pollen allergens rbet v 1 |
| 09/23/2009 | EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/23/2009 | EP1435935B1 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 09/23/2009 | EP1377288B1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and use |
| 09/23/2009 | CN101538545A Lactobacillus salivarius and food composition thereof |
| 09/23/2009 | CN101538521A Truffle soaking wine |
| 09/23/2009 | CN101538520A Tricholoma matsutake wine |
| 09/23/2009 | CN101538519A Pure-natural double-worm health-care rice wine and preparation method thereof |
| 09/23/2009 | CN101538320A Artificial zinc finger protein transcription factor capable of specifically regulating up HO-1 gene expression and application thereof |
| 09/23/2009 | CN101538293A Method for preparing secoisolariciresinol diglucoside and ferulic acid glucoside or ferulic acid glucoside ethyl ester |
| 09/23/2009 | CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/23/2009 | CN101538246A Pyrimidine amide compounds as pgds inhibitors |
| 09/23/2009 | CN101537169A Transfer factor solution for livestock and poultry, and preparation method thereof |
| 09/23/2009 | CN101537089A Pharmaceutical composition for curing allergic rhinitis and preparation method thereof |
| 09/23/2009 | CN101537082A Health wine capable of enhancing immunity and reliving physical fatigue and production method and applications thereof |
| 09/23/2009 | CN101537081A Matsutake health-care medicinal liquor with anticancer function and human body immunizing power enhancement function |
| 09/23/2009 | CN101537050A Health product capable of enhancing bone density and immune function, and preparation method and applications thereof |
| 09/23/2009 | CN101537048A Application of buckwheat and bee pollen in preparing drugs and method for preparing capsules and tablets thereby |
| 09/23/2009 | CN101537034A Functional health care product containing maca and preparation method thereof |
| 09/23/2009 | CN101537025A Preparation method for increasing content of total saponin, low polarity saponin and argininyl fructosy glucose in red ginseng |
| 09/23/2009 | CN101537020A Synbiotics of bacillus licheniformis and oligosaccharide class prebiotics and composition and formulation thereof |
| 09/23/2009 | CN101537015A Application of carbon nano-tubes in immunity accelerators for preparing anti-tumor immunotherapy medicaments |
| 09/23/2009 | CN101537003A Application of 7,3'-dimethoxy hesperetin in preparation of anti-inflammatory immune medicaments |
| 09/23/2009 | CN101536997A Application of ginseng alkynol in pharmacy |
| 09/23/2009 | CN101536978A Carboxymethyl starch sodium oral solution and preparation method thereof |
| 09/23/2009 | CN101536968A Cellular fluid of fresh flowers of roses and preparation method thereof |
| 09/23/2009 | CN101536854A Health-caring process quilt |
| 09/23/2009 | CN101536812A Health-care cigarette and manufacturing method thereof |
| 09/23/2009 | CN100543016C Intermediate compound of 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives |
| 09/23/2009 | CN100542606C Vaccine composition comprising tumour antigen and adjuvant composition |
| 09/22/2009 | US7592455 potent and selective inhibitors of p38 kinase, especially p38 alpha , p38 beta and p38 beta 2; immune or inflammatory disorders; Ethyl 3-(benzylamino)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592437 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/22/2009 | US7592340 Quinoxalines useful as inhibitors of protein kinases |
| 09/22/2009 | US7592329 containing an anti-inflammatory and anti-allergic compound of the androstane series |
| 09/22/2009 | US7592327 Asthma/allergy therapy that targets T-lymphocytes and/or eosinophils |
| 09/22/2009 | US7592171 Vibrio cholerae with improved biological safety features in freeze dried form |
| 09/22/2009 | US7592007 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
| 09/22/2009 | US7592006 Composition comprising the LO-CD2a antibody |
| 09/22/2009 | CA2399451C Tyrosine derivatives with anti-leukotriene activity |
| 09/22/2009 | CA2398274C Adenosine receptor modulators |
| 09/22/2009 | CA2360894C (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 09/17/2009 | WO2009114461A2 Angiotensin (1-7) dosage forms and uses thereof |
| 09/17/2009 | WO2009114085A2 Allogeneic cancer cell-based immunotherapy |
| 09/17/2009 | WO2009113910A1 Antiinflammatory and antiallergic gel |
| 09/17/2009 | WO2009113810A2 Pharmaceutical composition, use thereof, and method for the treatment or prevention of allergic and autoimmune diseases |
| 09/17/2009 | WO2009113743A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 09/17/2009 | WO2009113595A1 Method for producing cells having characteristic of hematopoietic stem cells/progenitor cells |
| 09/17/2009 | WO2009113423A1 Bicyclic pyrrole compound |
| 09/17/2009 | WO2009113083A1 A monoclonal antibody and a method thereof |
| 09/17/2009 | WO2009112603A1 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof |
| 09/17/2009 | WO2009112522A1 (E)-N-(2-Amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide salts |
| 09/17/2009 | WO2009112502A1 Agent for treating disease |
| 09/17/2009 | WO2009112490A1 Sulfonamides as zap-70 inhibitors |
| 09/17/2009 | WO2009112245A1 Antibody against the csf-1 r |
| 09/17/2009 | WO2009111998A2 Specific impurities of montelukast |
| 09/17/2009 | WO2009111948A1 The salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione or its derivatives, their polymorphs, preparation methods and uses thereof |
| 09/17/2009 | WO2009111893A1 Substituted pyrimidine compounds and their use as ifnar mediators |
| 09/17/2009 | WO2009046867A3 Caerulein alone or in combination with acth (3-24 ) as therapeutic agent |
| 09/17/2009 | WO2009046866A3 Trap-14 as a therapeutic agent |
| 09/17/2009 | WO2009040070A3 Use of helodermin as a therapeutic agent |
| 09/17/2009 | WO2009038671A3 Oxylipin compounds for treating autoimmune diseases |
| 09/17/2009 | US20090234000 Triptolide Analogs for the Treatment of Autoimmune and Inflammatory Disorders |
| 09/17/2009 | US20090233909 Sulfonamide compounds as cysteine protease inhibitors |
| 09/17/2009 | US20090233906 Imidazoazepinone compounds |
| 09/17/2009 | US20090233875 Glycolipids and analogues thereof as antigens for nk t cells |
| 09/17/2009 | US20090233855 Compounds and methods for modulating activation of nf-kb |
| 09/17/2009 | US20090233849 Recombinant Alpha-Fetoprotein, Method and Means for Preparation Thereof, Compositions on the Base Thereof and Use Thereof |
| 09/17/2009 | US20090233847 Coupling Proteins to a Modified Polysaccharide |
| 09/17/2009 | US20090233813 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 09/17/2009 | US20090233314 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration |
| 09/17/2009 | US20090232854 Uses of bispecific antibody coated dendritic cells pulsed with antigens and gm-csf in immune regulation |
| 09/17/2009 | US20090232845 Anti-peptide monoclonal antibodies (MAb's) specific for Exotic Newcastle Disease (END) are used for rapid diagnostic identification between poultry infected with vaccine strains of NDV (LaSota/B1) and END virus (ENDV) |
| 09/17/2009 | US20090232841 Optimzed vaccines to provide protection against ebola and other viruses |
| 09/17/2009 | US20090232834 Methods and Agents to Treat Autoimmune Diseases |
| 09/17/2009 | US20090232825 Methods and Compositions For Modulating Immunity |
| 09/17/2009 | US20090232803 Antibodies to human il-1beta |
| 09/17/2009 | US20090232802 Compositions and methods for the treatment of natural killer cell related diseases |
| 09/17/2009 | US20090232766 Compositions for Inducing Immune Response Comprising Inverted Microsomes |
| 09/17/2009 | US20090232736 Dual specificity antibodies and methods of making and using |
| 09/17/2009 | DE102008014077A1 New borrelidin derivatives are janus kinase 3 inhibitors useful e.g. for treating tumor, microbial infection, immune disorder and ophthalmic disease, inhibiting angiogenesis, and manufacturing herbicides and insecticides against arthropods |